Ventris Medical Received Additional FDA Clearance for Backpack® Bone Graft in the Intervertebral Disc Space
On April 08, 2025, Ventris Medical, a privately held leader in orthobiologics and tissue regeneration, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Backpack® product for use in the Intervertebral Disc Space. Backpack® introduces a new class of biomaterials designed to optimize cell proliferation and enhance bone formation, making it ideal for orthopedic and spinal fusion procedures. The product is available in two versions: one featuring a collagen mesh pouch filled with osteoinductive Allocell® A...
